Nothing was ordinary about the first civil trial stemming from Pfizer's controversial epilepsy treatment, Neurontin. Both sides loudly complained about witness intimidation. Colourful plaintiffs lawyer Mark Lanier opened to the jury one day, then settled the next after an anonymous donor deposited $50,000 (£31,000) into an account for the alleged victim's daughter. And at the defence table, high-powered product liability specialists from three separate firms worked as though they were partners - and all on a flat fee basis. "It was," says Pfizer general counsel Amy Schulman, "an extraordinary victory."
January 21, 2010 at 05:02 AM
1 minute read
The original version of this story was published on Legalweek
After a terrific run as a partner at DLA Piper, Pfizer’s Amy Schulman knows how the game is played and has set out to change all the rules. Amy Miller reports
Nothing was ordinary about the first civil trial stemming from Pfizer’s controversial epilepsy treatment, Neurontin.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
